Concepedia

Elizabeth Cauchon

EC

13

Publications

605

Citations

11

H-Index

2000

Active since

Affiliations

Merck Canada Inc. (Canada)(Current)

United States Military Academy

Merck & Co., Inc., Rahway, NJ, USA (United States)

Elizabeth Cauchon is an author at Merck Canada Inc. (Canada) specializing in medicine, drug discovery, and pharmacology.

Top concepts

Publications per year

2000–2013

13

Publications

13

Molecular pharmacology of the human prostaglandin D<sub>2</sub> receptor, CRTH2

Nicole Sawyer, Elizabeth Cauchon, Anne Châteauneuf et al. · British Journal of Pharmacology · 2002 · 189 citations · Full text

, , +16

<i>In Vitro</i>Characterization of MK-1439, a Novel HIV-1 Nonnucleoside Reverse Transcriptase Inhibitor

Ming‐Tain Lai, Meizhen Feng, Jean‐Pierre Falgueyret et al. · Antimicrobial Agents and Chemotherapy · 2013 · 140 citations · Full text

Discovery of MK-1439, an orally bioavailable non-nucleoside reverse transcriptase inhibitor potent against a wide range of resistant mutant HIV viruses

Bernard Côté, Jason D. Burch, Ernest Asante‐Appiah et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 97 citations

, , +11

Development of a homogeneous immunoassay for the detection of angiotensin I in plasma using AlphaLISA acceptor beads technology

Elizabeth Cauchon, Susana Liu, M. David Percival et al. · Analytical Biochemistry · 2009 · 33 citations

, , +4

Inhibition of human dermal fibroblast proliferation by removal of dermatan sulfate

Elizabeth M. Denholm, Elizabeth Cauchon, Catherine Poulin et al. · European Journal of Pharmacology · 2000 · 27 citations

, , +9

Rows per page

1–5 of 13